Possible mechanism for zinc protection against cadmium cytotoxicity in cultured vascular endothelial cells.
We investigated the effect of zinc on cadmium cytotoxicity in vascular endothelial cells in a culture system. The cytotoxicity was evaluated by [3H]adenine release assay. Cadmium at 2 microM concentration and above significantly increased the [3H]adenine release, but zinc at 80 microM and below did not induce such a response after a 24-h incubation. Metallothionein was induced by cadmium at 0.1 microM and above but not by zinc at 300 microM and below; however, zinc at 10 microM and above significantly decreased cadmium-(2 and 5 microM) induced cytotoxicity. Zinc protection against cadmium cytotoxicity was also observed in the presence of 1 microM cycloheximide. Zinc caused significantly less accumulation of cadmium in the cell layer accompanied with a significant accumulation of zinc. The distribution (%) of cadmium in the particulate fraction of the cells was significantly decreased by zinc. In contrast, cadmium in the cytosol fraction was increased in the cells treated with both cadmium and zinc. Gel filtration chromatography of the cytosol showed that cadmium was capable of being bound to high-molecular-weight proteins and metallothionein. The metallothionein-bound cadmium was not increased by zinc; however, the relative distribution of cadmium in the high-molecular-weight fraction in the cytosol was decreased in cadmium plus zinc-treated cells. From these results, it was suggested that the mechanism by which zinc protects endothelial cells from cadmium cytotoxicity was decreased accumulation of cadmium in the particulate fraction and in the high-molecular-weight fraction in the cytosol of the cells. This alteration is postulated to be caused by both zinc-induced decrease in the intracellular cadmium accumulation and the sequestration of cadmium by cadmium-induced metallothionein.
D000225:Adenine / Q000032:analysis; D000818:Animals; D002104:Cadmium / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics / Q000633:toxicity*; D002417:Cattle; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003600:Cytosol / Q000737:chemistry; D003911:Dextrans; D004347:Drug Interactions; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects*; D007700:Kinetics; D008668:Metallothionein / Q000502:physiology; D014176:Protein Biosynthesis; D014018:Tissue Distribution; D014316:Tritium; D014652:Vascular Diseases / Q000139:chemically induced / Q000517:prevention & control; D015032:Zinc / Q000494:pharmacology* / Q000627:therapeutic use
D003911:Dextrans; D002104:Cadmium; D014316:Tritium; C025614:sephadex; D008668:Metallothionein; D003513:Cycloheximide; D015032:Zinc; D000225:Adenine